CISH and hepatocellular carcinoma: The progression of HCC is linked to the enhanced activity of the JAK/STAT signaling pathway in the liver, a process affected by the epigenetic suppression of SOCS genes, inflammatory and oxidative stress, and growth factor stimulation [217].